UA26459C2 - Іhгібітор впливу амілоїдhих білків - Google Patents

Іhгібітор впливу амілоїдhих білків

Info

Publication number
UA26459C2
UA26459C2 UA94119085A UA94119085A UA26459C2 UA 26459 C2 UA26459 C2 UA 26459C2 UA 94119085 A UA94119085 A UA 94119085A UA 94119085 A UA94119085 A UA 94119085A UA 26459 C2 UA26459 C2 UA 26459C2
Authority
UA
Ukraine
Prior art keywords
inhibitor
amyloid proteins
influence
salt
amyloid
Prior art date
Application number
UA94119085A
Other languages
English (en)
Russian (ru)
Inventor
Уільям Генрі Уолкер ЛАHH
Original Assignee
Елі Ліллі Енд Компані
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Елі Ліллі Енд Компані, Эли Лилли Энд Компани filed Critical Елі Ліллі Енд Компані
Publication of UA26459C2 publication Critical patent/UA26459C2/uk

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4535—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a heterocyclic ring having sulfur as a ring hetero atom, e.g. pizotifen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A61K31/4025—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil not condensed and containing further heterocyclic rings, e.g. cromakalim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/10—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

Для інгібування вироблення амілоїдних білків застосовується сполука, що має формулу де R1 і R3 є незалежно воднем, де Ar є факультативно заміщеним фенилом;R2 вибирають з групи, що складається з пиіролідіно- і піперідіно-, або його фармацевтично прийнятній солі або сольвату.
UA94119085A 1993-12-01 1994-11-28 Іhгібітор впливу амілоїдhих білків UA26459C2 (uk)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US08/160,379 US6489355B2 (en) 1993-12-01 1993-12-01 Methods of inhibiting the effects of amyloidogenic proteins

Publications (1)

Publication Number Publication Date
UA26459C2 true UA26459C2 (uk) 1999-08-30

Family

ID=22576649

Family Applications (1)

Application Number Title Priority Date Filing Date
UA94119085A UA26459C2 (uk) 1993-12-01 1994-11-28 Іhгібітор впливу амілоїдhих білків

Country Status (14)

Country Link
US (1) US6489355B2 (uk)
EP (1) EP0663209A3 (uk)
JP (1) JPH07188010A (uk)
KR (1) KR950016720A (uk)
CN (1) CN1109750A (uk)
AU (1) AU673961B2 (uk)
CA (1) CA2136789A1 (uk)
CZ (1) CZ293194A3 (uk)
HU (1) HUT72297A (uk)
IL (1) IL111790A (uk)
NO (1) NO944577L (uk)
NZ (1) NZ270008A (uk)
UA (1) UA26459C2 (uk)
ZA (1) ZA949404B (uk)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5492927A (en) * 1993-12-21 1996-02-20 Eli Lilly And Company Non-peptide tachykinin receptor antagonists to treat allergy
ZA982877B (en) * 1997-04-09 1999-10-04 Lilly Co Eli Treatment of central nervous system disorders with selective estrogen receptor modulators.
US5990129A (en) * 1997-09-23 1999-11-23 Eli Lilly And Company Methods for regulating trkA expression
US6288108B1 (en) 1998-06-16 2001-09-11 Eli Lilly And Company Methods for increasing levels of acetylcholine
TR200003704T2 (tr) 1998-06-16 2001-06-21 Eli Lilly And Company Asetilkolin düzeylerini arttırma
CA2668744C (en) * 2006-11-17 2015-09-15 Queen's University At Kingston Compounds and methods for treating protein folding disorders
CN108186678A (zh) * 2018-01-10 2018-06-22 天津科技大学 羟基化碳纳米管在制备抑制β-淀粉样蛋白聚集的药物的用途

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4133814A (en) 1975-10-28 1979-01-09 Eli Lilly And Company 2-Phenyl-3-aroylbenzothiophenes useful as antifertility agents
US4380635A (en) 1981-04-03 1983-04-19 Eli Lilly And Company Synthesis of acylated benzothiophenes
US4418068A (en) 1981-04-03 1983-11-29 Eli Lilly And Company Antiestrogenic and antiandrugenic benzothiophenes
US5145892A (en) * 1985-12-19 1992-09-08 Chisso Corporation Polypropylene resin composition
US5075321A (en) 1987-03-24 1991-12-24 University Of Pennsylvania Methods of treating diseases characterized by interactions of IgG-containing immune complexes with macrophage Fc receptors using antiestrogenic benzothiophenes
US4960815A (en) * 1988-09-22 1990-10-02 Warner-Lambert Company Isotopically-labeled polycyclic amine derivatives
US5081304A (en) * 1988-09-22 1992-01-14 Warner-Lambert Company Isotopically-labeled polycyclic amine derivatives
US5395842A (en) 1988-10-31 1995-03-07 Endorecherche Inc. Anti-estrogenic compounds and compositions
GB9002834D0 (en) * 1990-02-08 1990-04-04 Ici America Inc Compounds
FR2663934B1 (fr) * 1990-06-27 1994-06-03 Adir Nouveaux derives de l'acide 4 - amino butyrique, leur procede de preparation et les preparations pharmaceutiques qui les contiennent.
US5214063A (en) * 1990-06-27 1993-05-25 Adir Et Compagnie 4-aminobutyric acid compounds, compositions and methods of use for treating disorders related to a dysfunction of GABAB receptors
US5189041A (en) * 1990-11-16 1993-02-23 Syntex (U.S.A.) Inc. Tricyclic 5-ht3 receptor antagonists
US5177074A (en) * 1991-03-26 1993-01-05 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5198438A (en) * 1991-05-07 1993-03-30 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted thiophene or furan
US5175164A (en) * 1991-06-05 1992-12-29 Merck & Co., Inc. Angiotensin ii antagonists incorporating a substituted indole or dihydroindole
JP3157882B2 (ja) * 1991-11-15 2001-04-16 帝国臓器製薬株式会社 新規なベンゾチオフエン誘導体
US5192220A (en) * 1992-01-31 1993-03-09 Amp Inc. Dual readout extended socket
TW366342B (en) * 1992-07-28 1999-08-11 Lilly Co Eli The use of 2-phenyl-3-aroylbenzothiophenes in inhibiting bone loss
US5288249A (en) * 1992-09-02 1994-02-22 Cooper Industries, Inc. Base for cartridge lamp
US5252524A (en) * 1992-10-16 1993-10-12 Corning Incorporated Polarizing glasses
TW383306B (en) * 1992-12-22 2000-03-01 Lilly Co Eli New use of 2-phenyl-3-aroylbenzothiophenes in lowering serum cholesterol
US5552415A (en) * 1993-12-21 1996-09-03 Eli Lilly And Company Method of inhibiting Alzheimer's Disease
JP4111352B2 (ja) 1996-05-21 2008-07-02 新日鐵住金ステンレス株式会社 ステンレス鋼の高清浄化精錬法

Also Published As

Publication number Publication date
IL111790A (en) 1998-10-30
EP0663209A2 (en) 1995-07-19
AU7909394A (en) 1995-06-08
JPH07188010A (ja) 1995-07-25
HUT72297A (en) 1996-04-29
HU9403422D0 (en) 1995-02-28
AU673961B2 (en) 1996-11-28
KR950016720A (ko) 1995-07-20
NO944577L (no) 1995-06-02
CN1109750A (zh) 1995-10-11
NZ270008A (en) 1997-07-27
US6489355B2 (en) 2002-12-03
EP0663209A3 (en) 1995-10-11
ZA949404B (en) 1996-05-28
CA2136789A1 (en) 1995-06-02
CZ293194A3 (en) 1995-07-12
IL111790A0 (en) 1995-01-24
US20010051368A1 (en) 2001-12-13
NO944577D0 (no) 1994-11-29

Similar Documents

Publication Publication Date Title
NO943495D0 (no) Kondenserte sykliske forbindelser og deres anvendelse
EA199800141A1 (ru) Гетероциклические соединения
NO996316L (no) Faktor Xa-inhibitorer med en noeytral P1-spesifisitetsgruppe
NL1002835A1 (nl) Synergistisch stabilisatormengsel.
MX9800804A (es) Derivados de pirrolidina que tienen actividad inhibitoria de la fosfolipasa a2.
DK0664126T3 (da) Hæmning af trombin
DK0641325T3 (da) Inhibitorer af retroviral protease
ES2189968T3 (es) Amidinofenil-pirrolidinas,-pirrolinas,e -isoxazolidinas y derivadOS DE LOS MISMOS.
TR199701654T1 (xx) 4-Fenilaminotiyazol t�revleri.
IL127574A0 (en) Inhibitors of prenyl transferases
LU92263I2 (fr) Imépitoïne et ses dérivés pharmaceutiquement acceptables (PEXION)
NO942740L (no) Pyridinkarboksimidamid-forbindelse og anvendelse av samme
DE69625505T2 (de) Guanidino proteiase inhibitoren
UA26459C2 (uk) Іhгібітор впливу амілоїдhих білків
ATE213241T1 (de) Amidin- und isothioharnstoffderivate als inhibitoren der stickstoffoxid-synthase
DE69813554D1 (de) Cyclische harnstoff- und lactamderivate von benzo(5,6)cycloheptapyridinen zur verwendung als farnesyl-protein-transferase-hemmer
ATE149159T1 (de) Heteroarylmethylbenzole-aromatasehemmer
ATE282608T1 (de) Chinoxalindionen
SV1998000088A (es) Compuestos farmaceuticos
FI904449A0 (fi) N-azasicyklo/3.3.0/oktanamider av aromatiska syror.
AU5230898A (en) Metalloproteinase inhibitors
RS50449B (sr) Supstituisani bisindolilmaleimidi za inhibiciju proliferacije ćelija
EE200000603A (et) Uudsed ühendid